Pyxis Oncology builds a differentiated portfolio of biologics, including antibody-drug conjugates and immunotherapies, to improve the lives of patients with difficult-to-treat cancers.
For more details on financing and valuation for Pyxis Oncology, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
PYXS
2.36 as of 3/20/23
To read this article and more news on Pyxis Oncology, register or login.
